Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study - The Lancet Respiratory Medicine
SP terá 3ª dose de vacina a partir de 6 de setembro, anuncia Doria - Saúde - Estadão
Governador João Doria recebe a segunda dose da Coronavac | Flickr
Laura Doria - Life Underwriting Consultant - MetLife | LinkedIn
ROVI Laboratorios Farmaceuticos - DORIA low risk, high reward | Edison
Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals | Science Translational Medicine
Sao Paulo state governor receives dose of Chinese Sinovac vaccine - Xinhua | English.news.cn
ROVI Laboratorios Farmaceuticos - DORIA low risk, high reward | Edison
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ
Governador João Doria recebe a segunda dose da Coronavac | Flickr
Brazil Begins Vaccinating Children Despite President's Objection – Channels Television
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study - eClinicalMedicine
Sao Paulo, Brazil. June 4 2021: The Governor of São Paulo João Doria, (PSDB) receives the second dose of the vaccine against Covid-19 (Coronavirus) at the Doctor Victor Araújo Homem de Mello
SÃO PAULO, SP - 07.05.2021: DORIA RECEIVES FIRST DOSE VACCINE -The governor of the State of São Paulo, João Doria (PSDB) and his wife Bia Doria received this Friday afternoon on May
Application of analytical techniques in quality control of printed pharmaceutical dosage forms - Doria
Efficacy and safety of a 3rd dose of mRNA-1273 SARS-CoV-2 vaccine
Doria anuncia aplicação da 4ª dose em idosos em São Paulo
Brazil Approves Emergency Use of Sinovac, AstraZeneca Shots - Bloomberg
High-dose vs low-dose steroid in pregnancy patients... | F1000Research
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 | NEJM
Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials -
Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants | Nature Medicine
Governador João Doria recebe a segunda dose da Coronavac | Flickr
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ
Effect of live yeast Saccharomyces cerevisiae supplementation on the performance and cecum microbial profile of suckling piglets | PLOS ONE
